Spectrum Asset Management, Inc. Biogen Inc. Transaction History

Spectrum Asset Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$242.95 - $284.63 $285,466 - $334,440	-1,175 Closed	0 $0
Q4 2020 Jan 20, 2021	SELL	$236.26 - $355.63 $1.27 Million - $1.9 Million	-5,355 Reduced 82.01%	1,175 $288,000
Q1 2020 Apr 22, 2020	BUY	$268.85 - $341.04 $1.76 Million - $2.23 Million	6,530 New	6,530 $2.07 Million

1,006

129M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Spectrum Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Spectrum Asset Management, Inc. with notifications on news.